-
#ECTRIMS2018 – For MS Spasticity, 2 EU Trials Show Efficacy of Sativex
Data from two European trials supported the efficacy of Sativex cannabinoid spray in treating spasticity in multiple sclerosis patients. Click here to read more about it.
Do you suffer from spasticity? Is this medication part of your treatment plan?
Sorry, there were no replies found.
Log in to reply.